feed,title,long_url,short_url
SeekingAlpha,"Edwards Life Sciences: 15.76% FCF Margin, But With 6.67% Downside Risk And 30% Overvaluation - Time To Prove It",https://seekingalpha.com/article/4364757,
SeekingAlpha,"After A Stellar Q3, It Might Be Time To Think About Scotts Miracle-Gro",https://seekingalpha.com/article/4364755,
SeekingAlpha,"Aptose: Boring Today, But Things Could Get Exciting Later This Year",https://seekingalpha.com/article/4364754,
